Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in Breast cancer
- 1 January 1994
- book chapter
- Published by Springer Nature
- Vol. 71, 299-309
- https://doi.org/10.1007/978-1-4615-2592-9_16
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993
- Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a reviewBreast Cancer Research and Treatment, 1993
- Invasion of the trophoblastsCell, 1992
- Type‐1 plasminogen activator inhibitor in human breast carcinomasInternational Journal of Cancer, 1992
- Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast CancerSeminars in Thrombosis and Hemostasis, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.The Journal of cell biology, 1990
- Tissue-Type Plasminogen ActivatorDrugs, 1989
- Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modulesCell, 1985
- Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma.The Journal of cell biology, 1984